Drug Trial Radar · NCT02064049
Surveillance and Treatment of Prisoners With Hepatitis C
Last checked: Nov 19, 2026Latest source record: Dec 9, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,692
Actual
Start
Oct 2014
Primary completion
Nov 2019
Study completion Nov 2019
Sponsor
- Lead sponsor
- Kirby InstituteGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Feb 17, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess how feasible it is to treat and prevent the transmission of Hepatitis C in the prison setting to achieve substantial reductions in the incidence and prevalence of Hepatitis C. It is hypothesised that a rapid scale-up of Hepatitis C Virus (HCV) treatment with interferon-free Direct Acting Anti-virals (DAAs) in prison inmates will achieve a \>50% reduction in the incidence of HCV infection over a two year period in the prison setting.
Conditions
- Hepatitis C
Interventions
Sofosbuvir/velpatasvirDrug
The treatment phase will commence in year 2. This is 12 weeks of the pangenotypic sofosbuvir/velpatasvir 400/100mg, coformulated into one tablet daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hepatitis C virus (HCV) incidenceTime frame: 2 years
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Goulburn Correctional Centre
Goulburn, New South Wales, Australia
Lithgow Correctional Centre
Lithgow, New South Wales, Australia
Dillwynia Correctional Centre
Windsor, New South Wales, Australia
Outer Metropolitan Multipurpose Correctional Centre
Windsor, New South Wales, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.